{"title":"Hydroxypropyl methylcellulose-induced urticaria and angioedema: a case report.","authors":"Won Jin Lee, Eun-Jung Jo, Hye-Kyung Park","doi":"10.1186/s13223-026-01021-5","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Hydroxypropyl methylcellulose (HPMC) is a food additive widely used as an excipient in oral pharmaceutical formulations. While widely used in oral formulations, its potential as an ingestible allergen remains largely unrecognized.</p><p><strong>Case presentation: </strong>A 47-year-old man developed urticaria and angioedema after ingesting an HPMC-containing product, including a dietary probiotic drink and a digestive enzyme tablet. He presented with periorbital swelling and generalized urticaria within one hour after consuming a dietary probiotic drink. Two months prior, the patient experienced generalized urticaria and facial swelling after concomitant intake of a vitamin C drink and a digestive enzyme tablet. Skin prick tests revealed positive reactions to the capsule shell of the probiotic drink and digestive enzyme tablet. HPMC was identified as a common excipient in both digestive enzyme tablet and the capsule shell of dietary probiotic drinks and intradermal tests confirmed hypersensitivity to HPMC. An oral provocation test with HPMC induced urticaria, further supporting the diagnosis.</p><p><strong>Conclusions: </strong>This case demonstrates that HPMC can induce immediate hypersensitivity reactions via the oral route. HPMC should be considered a potential culprit in patients with unexplained recurrent allergic reactions to oral medications or dietary supplements, particularly when multiple formulations are involved.</p>","PeriodicalId":51302,"journal":{"name":"Allergy Asthma and Clinical Immunology","volume":" ","pages":""},"PeriodicalIF":2.4000,"publicationDate":"2026-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13081250/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Allergy Asthma and Clinical Immunology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s13223-026-01021-5","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ALLERGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Hydroxypropyl methylcellulose (HPMC) is a food additive widely used as an excipient in oral pharmaceutical formulations. While widely used in oral formulations, its potential as an ingestible allergen remains largely unrecognized.
Case presentation: A 47-year-old man developed urticaria and angioedema after ingesting an HPMC-containing product, including a dietary probiotic drink and a digestive enzyme tablet. He presented with periorbital swelling and generalized urticaria within one hour after consuming a dietary probiotic drink. Two months prior, the patient experienced generalized urticaria and facial swelling after concomitant intake of a vitamin C drink and a digestive enzyme tablet. Skin prick tests revealed positive reactions to the capsule shell of the probiotic drink and digestive enzyme tablet. HPMC was identified as a common excipient in both digestive enzyme tablet and the capsule shell of dietary probiotic drinks and intradermal tests confirmed hypersensitivity to HPMC. An oral provocation test with HPMC induced urticaria, further supporting the diagnosis.
Conclusions: This case demonstrates that HPMC can induce immediate hypersensitivity reactions via the oral route. HPMC should be considered a potential culprit in patients with unexplained recurrent allergic reactions to oral medications or dietary supplements, particularly when multiple formulations are involved.
期刊介绍:
Allergy, Asthma & Clinical Immunology (AACI), the official journal of the Canadian Society of Allergy and Clinical Immunology (CSACI), is an open access journal that encompasses all aspects of diagnosis, epidemiology, prevention and treatment of allergic and immunologic disease.
By offering a high-visibility forum for new insights and discussions, AACI provides a platform for the dissemination of allergy and clinical immunology research and reviews amongst allergists, pulmonologists, immunologists and other physicians, healthcare workers, medical students and the public worldwide.
AACI reports on basic research and clinically applied studies in the following areas and other related topics: asthma and occupational lung disease, rhinoconjunctivitis and rhinosinusitis, drug hypersensitivity, allergic skin diseases, urticaria and angioedema, venom hypersensitivity, anaphylaxis and food allergy, immunotherapy, immune modulators and biologics, immune deficiency and autoimmunity, T cell and B cell functions, regulatory T cells, natural killer cells, mast cell and eosinophil functions, complement abnormalities.